Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population-Based Cohort Study

Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis

(2014) E. Cairoli et al.   OSTEOPOROSIS INTERNATIONAL

Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective

(2014) L. Hansen et al.   OSTEOPOROSIS INTERNATIONAL

Predictors of Fracture While on Treatment With Oral Bisphosphonates: A Population-Based Cohort Study

(2013) Daniel Prieto-Alhambra et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

(2013) Adolfo Díez-Pérez et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs—an analysis using national health databases

(2013) K. R. Olsen et al.   OSTEOPOROSIS INTERNATIONAL

Osteoporosis in the European Union: medical management, epidemiology and economic burden

(2013) E. Hernlund et al.   Archives of Osteoporosis

“Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study”

(2012) Aina Pagès-Castellà et al.   BMC MUSCULOSKELETAL DISORDERS

Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments

(2012) Charles A. Inderjeeth et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Treatment failure in osteoporosis

(2012) A. Diez-Perez et al.   OSTEOPOROSIS INTERNATIONAL

Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study

(2012) B. Abrahamsen et al.   OSTEOPOROSIS INTERNATIONAL

Proton Pump Inhibitor Use and the Antifracture Efficacy of Alendronate

(2011) Bo Abrahamsen et al.   ARCHIVES OF INTERNAL MEDICINE

Risk factors for prediction of inadequate response to antiresorptives

(2011) Adolfo Díez-Pérez et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The societal burden of poor persistence to treatment of osteoporosis in Sweden

(2010) Erik Landfeldt et al.   BONE

Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus

(2009) M. Saito et al.   OSTEOPOROSIS INTERNATIONAL

Differences in persistence among different weekly oral bisphosphonate medications

(2008) O. Sheehy et al.   OSTEOPOROSIS INTERNATIONAL

Osteoporosis treatment and fracture incidence: the ICARO longitudinal study

(2008) S. Adami et al.   OSTEOPOROSIS INTERNATIONAL

Spectroscopic markers of bone quality in alendronate-treated postmenopausal women

(2008) A. L. Boskey et al.   OSTEOPOROSIS INTERNATIONAL

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Medication Compliance and Persistence: Terminology and Definitions

(2007) Joyce A. Cramer et al.   VALUE IN HEALTH